Oxford Science Enterprises
Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI &a; software, and deep tech.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Oxford Science Enterprises Information
Geographic Data
Address: 46 Woodstock Road
City: Oxford
State: england
Zip: OX2 6HT
Country: GB
Financial Info
Stage:
Raised Last:
$299M
Raised Total:$300M
Social
Twitter
Linkedin
Crunchbase
Metrics
4,299,602Website Global Rank
2,884Website Monthly Traffic
Twitter Followers
Description
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2021 | Ultromics | Series B | 0 |
| 11/2020 | Refeyn | Series A | 30M |
| 9/2019 | YASA | Series C | 22.2M |
| 12/2017 | Navenio | Funding Round | 7.7M |
| 5/2020 | Navenio | Series A | 0 |
| 2/2023 | Quantum Motion | Series B | 0 |
| 8/2018 | BioBeats | Seed Round | 3M |
| 5/2020 | Quantum Motion Technologies | Series A | 9.8M |
| 12/2017 | Theolytics | Seed Round | 3.4M |
| 4/2022 | OMass Technologies | Series B | 0 |
| 8/2017 | OxMet Technologies | Seed Round | 2.6M |
| 5/2017 | Ultromics | Seed Round | 2.6M |
| 11/2016 | Vaccitech | Seed Round | 12.4M |
| 5/2016 | Evox Therapeutics | Series A | 14.4M |
| 2/2022 | First Light Fusion | Series C | 45M |
| 12/2021 | Alethiomics | Seed Round | 8M |
| 6/2020 | Oxford Ionics | Seed Round | 3.4M |
| 12/2016 | EnzBond | Seed Round | 445.3k |
| 1/2016 | Oxford Flow | Seed Round | - |
| 3/2016 | Diffblue | Seed Round | - |
| 6/2022 | ORCA Computing | Series A | 15M |
| 10/2016 | DJS Antibodies | Seed Round | - |
| 8/2018 | Edplus | Pre Seed Round | 643.5k |
| 5/2019 | Albus Health | Convertible Note | 580.9k |
| 9/2018 | Oxford VR | Venture Round | 4.2M |
| 7/2022 | Oxford Quantum Circuits | Series A | 45.4M |
| 3/2017 | Oxford Semantic Technologies | Seed Round | - |
| 5/2021 | Omega Crop | Seed Round | 1.7M |
| 6/2017 | Scenic Biotech | Series A | 7.3M |
| 1/2016 | Mixergy Ltd. | Seed Round | - |
| 12/2018 | Genomics | Series B | 9.1M |
| 3/2021 | Genomics | Venture Round | 30M |
| 10/2016 | Argonaut Therapeutics | Seed Round | - |
| 11/2017 | Quantum Motion Technologies | Seed Round | - |
| 1/2020 | OxMet Technologies | Series B | 14.1M |
| 1/2018 | Pepgen | Seed Round | - |
| 11/2015 | Bodle Technologies | Seed Round | - |
| 6/2015 | OxStem | Seed Round | - |
| 7/2021 | Orbit Discovery | Venture Round | 0 |
| 7/2019 | Zegami | Series B | 1.6M |
| 4/2020 | BibliU | Series A | 10M |
| 12/2021 | ONI | Series B | 75M |
| 4/2018 | Oxford Flow | Venture Round | 8.5M |
| 1/2017 | Covatic | Seed Round | 896.6k |
| 3/2021 | Caristo Diagnostics | Venture Round | - |
| 7/2016 | Oxford Impedance Diagnostics Ltd. | Seed Round | 2.6M |
| 2/2017 | BibliU | Seed Round | 1.4M |
| 7/2018 | ONI | Series A | 24M |
| 2/2020 | Oxford VR | Series A | 0 |
| 10/2018 | Caristo Diagnostics | Seed Round | 2.6M |
| 12/2016 | Circadian Therapeutics | Venture Round | 2.5M |
| 1/2021 | Living Optics | Seed Round | 0 |
| 5/2018 | Orbit Discovery | Series A | 0 |
| 11/2017 | First Light Fusion | Venture Round | - |
| 1/2017 | Oxford VR | Seed Round | - |
| 10/2018 | Animal Dynamics | Series A | 0 |
| 6/2018 | BibliU | Seed Round | 3.8M |
| 3/2018 | Xerion Healthcare | Venture Round | 2.8M |
| 3/2022 | Scenic Biotech | Series A | 0 |
| 8/2019 | MoA Technology | Series A | 7.6M |
| 11/2022 | Util | Seed Round | 0 |
| 5/2018 | Ultromics | Series A | 0 |
| 6/2022 | BibliU | Series B | 0 |
| 9/2018 | Evox Therapeutics | Series B | 0 |
| 6/2018 | Metaboards | Series A | 0 |
| 12/2021 | Navenio | Venture Round | 0 |
| 7/2020 | PQShield | Seed Round | 6.9M |
| 7/2019 | Zegami | Series B | 1.6M |
| 7/2021 | Rey | Series A | 10M |
| 4/2023 | Caristo Diagnostics | Series A | 0 |
| 3/2023 | Mixergy | Venture Round | 0 |
| 3/2023 | Quantrol Ox | Seed Round | 0 |
| 2/2023 | Archangel Lightworks | Seed Round | 0 |
| 12/2022 | BehaVR | Series B | 0 |
| 6/2020 | Base Genomics | Seed Round | 11.3M |
| 1/2023 | Grey Wolf Therapeutics | Series B | 0 |
| 5/2018 | Opsydia | Seed Round | 2.5M |
| 6/2023 | Beacon Therapeutics | Series A | 0 |
| 7/2020 | ORCA Computing | Pre Seed Round | - |
| 2/2018 | Odqa Renewable Energy Technologies | Seed Round | 570.6k |
| 12/2019 | Mixergy Ltd. | Series A | 0 |
| 9/2022 | Opsydia | Venture Round | 0 |
| 5/2016 | ONI | Seed Round | 1.7M |
| 10/2019 | MiroBio | Series A | 33.2M |
| 6/2020 | Oxford Flow | Venture Round | 0 |
| 6/2022 | MiroBio | Series B | 0 |
| 6/2019 | Oxford Semantic Technologies | Series A | 3.8M |
| 4/2020 | Perspectum | Series B | 35.9M |
| 8/2017 | Inkpath | Series A | - |
| 5/2018 | PQShield | Seed Round | - |
| 2/2018 | Latent Logic | Seed Round | 2M |
| 2/2021 | Evox Therapeutics | Series C | 96.7M |
| 5/2018 | Util | Seed Round | 1.1M |
| 10/2018 | Covatic | Seed Round | 1.1M |
| 12/2020 | DJS Antibodies | Venture Round | 0 |
| 3/2021 | Vaccitech | Series B | 168M |
| 1/2023 | Amber Therapeutics | Seed Round | - |
| 6/2015 | Proxisense | Seed Round | - |
| 3/2017 | Bodle Technologies | Seed Round | - |
| 8/2021 | Pepgen | Venture Round | 0 |
| 9/2016 | Iota Sciences | Seed Round | - |
| 11/2017 | Albus Health | Convertible Note | 66.6k |
| 1/2022 | PQShield | Series A | 0 |
| 6/2017 | Diffblue | Series A | 21.8M |
| 11/2018 | OMass Technologies | Series A | 17.9M |
| 12/2015 | Navenio | Seed Round | 2.6M |
| 5/2022 | Salience Labs | Seed Round | 11.5M |
| 12/2020 | Pepgen | Series A | 45M |
| 7/2022 | Brill Power | Series A | 0 |
| 3/2017 | SpyBiotech | Seed Round | 5M |
| 6/2016 | OMass Technologies | Seed Round | 1.4M |
| 1/2018 | Bodle Technologies | Series A | 8.5M |
| 2/2020 | OMass Technologies | Series A | 35.8M |
| 12/2020 | T-Cypher Bio | Seed Round | - |
| 9/2011 | Oxtex | Seed Round | 800k |
| 1/2023 | Oxford Ionics | Series A | 0 |
| 9/2017 | Oxford Quantum Circuits | Series A | - |
| 1/2018 | Vaccitech | Series A | 0 |
| 2/2016 | Mind Foundry | Seed Round | 1.7M |
| 1/2021 | Theolytics | Series A | 6.8M |
| 11/2022 | Osler Diagnostics | Series C | 0 |
| 6/2017 | Zegami | Series A | 3M |
| 10/2022 | Nucleome Therapeutics | Series A | 42.3M |
| 5/2022 | MoA Technology | Series B | 0 |
| 8/2018 | Genomics | Series B | 32.5M |
| 11/2018 | OxMet Technologies | Series A | 7.8M |
| 9/2018 | Oxford VR | Seed Round | 4.2M |
| 4/2020 | Living Optics | Seed Round | 4.1M |
| 3/2017 | Pro-Mapp | Seed Round | - |
| 4/2017 | ONI | Seed Round | 3.7M |
| 3/2018 | 6D.ai | Seed Round | - |
| 9/2017 | Mind Foundry | Seed Round | 3.4M |
| 4/2021 | Oxford Endovascular | Series A | 0 |
| 2/2021 | SpyBiotech | Series A | 32.5M |
| 4/2023 | Caristo Diagnostics | Series A | 0 |
| 3/2023 | Mixergy | Venture Round | 0 |
| 3/2023 | Quantrol Ox | Seed Round | 0 |
| 2/2023 | Quantum Motion | Series B | 0 |
| 2/2023 | Archangel Lightworks | Seed Round | 0 |
| 1/2023 | Grey Wolf Therapeutics | Series B | 0 |
| 1/2023 | Amber Therapeutics | Seed Round | - |
| 1/2023 | Oxford Ionics | Series A | 0 |
| 12/2022 | BehaVR | Series B | 0 |
| 11/2022 | Osler Diagnostics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
